In the Spotlight
Hot off the press! Just published in Clinical Cancer Research: Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in BRAF-Mutant Melanoma, Antoni Ribas, et al. Find out more.
Read the new Molecular Cancer Therapeutics Targeting First Disclosures in Cancer Therapeutics Collection, which highlights a few examples of the Journal’s latest initiative – enhancing its role as the source for the first-time disclosure of cancer therapeutics and highlighting that science to readers.
New collections! Check out the Cancer Immunology Research collections: Immunotherapy Trials and Tribulations and Toolbox: Signatures and Cells. Complimentary access is available for a limited time!
Just published to coincide with its presentation at the International Conference on Molecular Targets and Cancer Therapeutics, read The KRASG12C Inhibitor, MRTX849, Provides Insight Toward Therapeutic Susceptibility of KRAS Mutant Cancers in Mouse Models and Patients, in Cancer Discovery!
Keep up with “what’s new” by following the AACR Journals on Twitter:
@CD_AACR: Cancer Discovery
@CEBP_AACR: Cancer Epidemiology, Biomarkers & Prevention
@CIR_AACR: Cancer Immunology Research
@CAPR_AACR: Cancer Prevention Research
@CR_AACR: Cancer Research
@CCR_AACR: Clinical Cancer Research
@MCR_AACR: Molecular Cancer Research
@MCT_AACR: Molecular Cancer Therapeutics
